Showing results (161-170 of 303) with videos related to

Sort By:
Pageof 31
Journal of Virology|January 1, 1996
Use of recombinant protein to identify a motif-negative human cytotoxic T-cell epitope presented by HLA-A2 in the hepatitis C virus NS3 regionK Kurokohchi, T Akatsuka, C D Pendleton, et al.
Digestive Diseases and Sciences|December 1, 1996
Pathogenesis of chronic liver disease in patients with chronic hepatitis B virus infection without serum HBeAgA Mangia, Y H Chung, J H Hoofnagle, et al.
Canadian Medical Association Journal|November 1, 1982
Prevalence of antibody to hepatitis A virus in a Canadian Inuit communityG Y Minuk, J G Waggoner, R Jernigan, et al.
Gastroenterology|November 1, 1989
Inhibition of duck hepatitis B virus replication by 2',3'-dideoxycytidine. A potent inhibitor of reverse transcriptaseC Kassianides, J H Hoofnagle, R H Miller, et al.
Hepatology (Baltimore, Md.)|October 2, 1998
10-Year follow-up after interferon-alpha therapy for chronic hepatitis CD T Lau, D E Kleiner, M G Ghany, et al.
Gastroenterology|January 1, 1986
Pilot study of recombinant human alpha-interferon for chronic type B hepatitisJ S Dooley, G L Davis, M Peters, et al.
American Journal of Epidemiology|April 1, 1985
The changing epidemiology of hepatitis B virus infection in the Canadian northG Y Minuk, N Ling, B Postl, et al.
Scandinavian Journal of Infectious Diseases|January 1, 1986
Cross-sectional seroepidemiologic study of the prevalence of cytomegalovirus and herpes simplex virus infection in a Canadian Inuit (Eskimo) communityL E Nicolle, G Y Minuk, B Postl, et al.
The American Journal of Gastroenterology|November 1, 1996
Use of quantitative assays for hepatitis B e antigen and IgM antibody to hepatitis B core antigen to monitor therapy in chronic hepatitis BP H Hayashi, M P Beames, M C Kuhns, et al.
Hepatology (Baltimore, Md.)|July 1, 1991
The significance of antibody to hepatitis C virus in patients with chronic hepatitis BT L Fong, A M Di Bisceglie, J G Waggoner, et al.
Pageof 31